Orphai Therapeutics INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.2Mgeneral payments (2019-2025)
$1.4Mresearch payments (2019-2025)
40clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Murat Gunel | New Haven, CT | Neurological Surgery | $692,000.00 |
| Langdon Miller | Seattle, WA | Hematology & Oncology | $456,225.00 |
| Donald Mahler | Lebanon, NH | Pulmonary Disease | $14,000.00 |
| Lydia Gilbert-Mcclain | Bethesda, MD | Critical Care Medicine (Internal Medicine) | $10,129.17 |
| Stephen Strittmatter | New Haven, CT | Neurology (Psychiatry & Neurology) | $10,000.00 |
| Caroline Shiboski | San Francisco, CA | Dentist | $7,500.00 |
| Robert Bourge | Birmingham, AL | Cardiovascular Disease | $5,000.00 |
| Patrick Grohar | Ann Arbor, MI | Pediatric Hematology-Oncology | $4,750.00 |
| Marianne Mann | Highland, MD | Internal Medicine | $4,400.00 |
| Lewis Rubin | La Jolla, CA | Internal Medicine | $3,687.50 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.